Clinical Trial Update: Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial update examining how dabigatran and phenprocoumon influence clopidogrel-mediated platelet aggregation in patients with atrial fibrillation and cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Atrial Fibrillation
• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Phenprocoumon (phenprocoumon)
• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Heart Disease, Atrial Fibrillation | Phase 4 | Status: TERMINATED